Legend Biotech (LEGN) Research & Development (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Research & Development data on file, last reported at $85.7 million in Q1 2026.

• Quarterly Research & Development fell 15.9% year-over-year to $85.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$227.0 million (down 7.79% YoY) and the FY2025 annual result came in at -$414.7 million, changed 0.29% from the prior year.
• Research & Development improved to $85.7 million in Q1 2026, from -$101.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $101.9 million in Q1 2025 to a low of -$113.1 million in Q3 2025.
• A 5-year average of -$67.7 million and a median of -$95.8 million in 2023 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development sank 114639.98% — and 2025, when it jumped 200.93%.
• Tracing LEGN's Research & Development over 5 years: stood at -$80.8 million in 2022, then jumped by 99.87% to -$105683.0 in 2023, then slumped by 98685.99% to -$104.4 million in 2024, then advanced by 2.97% to -$101.3 million in 2025, then jumped by 184.6% to $85.7 million in 2026.
• The last three Research & Development figures came in at $85.7 million (Q1 2026), -$101.3 million (Q4 2025), and -$113.1 million (Q3 2025), per Business Quant data.